Polyphenolic Compounds Inhibit Osteoclast Differentiation While Reducing Autophagy through Limiting ROS and the Mitochondrial Membrane Potential
Related Experiment Video
Updated: Aug 28, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Dipranjan Laha1, Jaganmay Sarkar1, Jyotirindra Maity1
1Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Abstract:
Polyphenolic compounds are a diverse group of natural compounds that interact with various cellular proteins responsible for cell survival, differentiation, and apoptosis. However, it is yet to be established how these compounds interact in myeloid cells during their differentiation and the molecular and intracellular mechanisms involved. Osteoclasts are multinucleated cells that originate from myeloid cells. They resorb cartilage and bone, maintain bone homeostasis, and can cause pathogenesis. Autophagy is a cellular mechanism that is responsible for the degradation of damaged proteins and organelles within cells and helps maintain intracellular homeostasis. Imbalances in autophagy cause various pathological disorders. The current study investigated the role of several polyphenolic compounds, including tannic acid (TA), gallic acid (GA), and ellagic acid (EA) in the regulation of osteoclast differentiation of myeloid cells. We demonstrated that polyphenolic compounds inhibit osteoclast differentiation in a dose-dependent manner. Quantitative real-time PCR, immunocytochemistry, and western blotting revealed that osteoclast markers, such as NFATc1, Cathepsin K, and TRAP were inhibited after the addition of polyphenolic compounds during osteoclast differentiation. In our investigation into the molecular mechanisms, we found that the addition of polyphenolic compounds reduced the number of autophagic vesicles and the levels of LC3B, BECN1, ATG5, and ATG7 molecules through the inactivation of Akt, thus inhibiting the autophagy process. In addition, we found that by decreasing intracellular calcium and decreasing ROS levels, along with decreasing mitochondrial membrane potential, polyphenolic compounds inhibit osteoclast differentiation. Together, this study provides evidence that polyphenolic compounds inhibit osteoclast differentiation by reducing ROS production, autophagy, intracellular Ca2+ level, and mitochondrial membrane potentials.
Insights
Polyphenolic compounds like tannic acid inhibit myeloid cell differentiation into osteoclasts. These natural compounds reduce markers of osteoclast activity, autophagy, and intracellular calcium levels.
Area of Science:
- Biochemistry
- Cell Biology
- Natural Products Chemistry
Background:
- Polyphenolic compounds are natural substances with diverse cellular interactions.
- Osteoclasts, derived from myeloid cells, are crucial for bone homeostasis and resorption.
- Autophagy is a key cellular process for maintaining homeostasis, and its dysregulation is linked to pathology.
Purpose of the Study:
- To investigate the role of polyphenolic compounds in regulating myeloid cell differentiation into osteoclasts.
- To elucidate the molecular and intracellular mechanisms underlying this regulation.
Main Methods:
- Quantitative real-time PCR, immunocytochemistry, and western blotting were used to assess osteoclast differentiation markers.
- Analysis of autophagic vesicles and key autophagy-related proteins (LC3B, BECN1, ATG5, ATG7).
- Measurement of intracellular calcium, reactive oxygen species (ROS) levels, and mitochondrial membrane potential.
Main Results:
- Polyphenolic compounds (tannic acid, gallic acid, ellagic acid) inhibited osteoclast differentiation in a dose-dependent manner.
- Osteoclast markers (NFATc1, Cathepsin K, TRAP) were significantly reduced.
- Inhibition of autophagy via Akt inactivation and reduction in autophagic vesicles and proteins.
- Decreased intracellular calcium, ROS levels, and mitochondrial membrane potential were observed.
Conclusions:
- Polyphenolic compounds effectively inhibit osteoclast differentiation.
- The mechanism involves the suppression of autophagy, reduction of ROS production, and modulation of intracellular calcium and mitochondrial function.
- These findings highlight the potential of polyphenolic compounds in managing bone-related disorders involving osteoclast activity.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Osteoclasts in Bone Remodeling
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

